Concepedia

Katerina Bakunina

KB

11

Publications

665

Citations

11

H-Index

2019

Active since

Affiliations

University Medical Center Utrecht(Current)

Erasmus MC Cancer Institute

University Medical Center Groningen

Leiden University Medical Center

Amsterdam University Medical Centers

Katerina Bakunina is an author at University Medical Center Utrecht specializing in cancer research, pathology, and medicine.

ORCID

Top concepts

Publications per year

2019–2022

11

Publications

11

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

Jacoline E. C. Bromberg, Samar Issa, Katerina Bakunina et al. · The Lancet Oncology · 2019 · 229 citations

, , +9

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Annoek E. C. Broers, Cornelis N. de Jong, Katerina Bakunina et al. · Blood Advances · 2022 · 105 citations · Full text

Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis

Michael H. Albert, Mary Slatter, Andrew R. Gennery et al. · Blood · 2022 · 73 citations · Full text

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

Martine E.D. Chamuleau, Coreline N. Burggraaff, Marcel Nijland et al. · Haematologica · 2019 · 52 citations · Full text

, , +16

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Michael H. Albert, Tiarlan Sirait, Dirk-Jan Eikema et al. · Blood · 2022 · 51 citations · Full text

Rows per page

1–5 of 11